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Clinical autonomy remains one of the most valued 
characteristics of our profession. Most physicians remain 
fiercely attached to clinical autonomy and believe it is vital to 
practicing the science and the art of medicine. Although advances 
in medical science and the effectiveness of medical practice have long
served to earn us this autonomy, the combined forces of payer and
governmental regulation, changing expectations of patients and our
clinical performance have altered how society views our profession.
This changing view has resulted in an erosion of autonomy over the 
past few decades. Society has learned that the basis for this autonomy,
our scientific knowledge and extensive training, has not been
consistently applied for their benefit. 
There certainly are many important examples of the appropriate and
consistent application of science to which we can all point. Within
CentraCare, we have seen significant impact from using evidence-based
medicine, standardization and a multidisciplinary approach to the
delivery of health care. Our cardiologists, through the STEMI program,
have achieved remarkably low, 3 percent overall in-hospital mortality
for patients with an acute myocardial infarction. Our Intensivists have
created an ICU recognized nationally for providing clinical innovation
and improved outcomes while reducing cost. Nevertheless, countless
national studies continue to demonstrate unexplained practice variation
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Team-based medicine and the use
of clinical guidelines and protocols
By Allen Horn, MD, MBA, FACPE 
President, CentraCare Clinic
continued on inside
President’s Message 
continued from cover
across physicians and regions, and widespread
quality and safety problems of overuse, underuse
and misuse. 
If clinical autonomy is a good thing, and we 
wish to regain or maintain it, we will not do 
so by a focus on feeling victimized or by loudly
lamenting our loss. The most effective approach,
the professional approach, will require that 
we no longer define or maintain autonomy at 
the individual physician level, but rather move
toward creation of a renewed focus on team-based
medicine, standardization and the use of clinical
guidelines and protocols. In addition, we need to
join together as colleagues and do a better job of
policing our own profession, by dealing firmly
and effectively with those of our colleagues who
do not fulfill their professional obligations of
quality and integrity. 
From society’s perspective, such accountability
certainly can serve to identify and sanction
incompetent or crooked physicians, but for our
profession it can better serve to influence
physicians to practice evidence-based medicine 
by making more effective use of the very science
on which we base our profession. Only by
consistently practicing the science of medicine 
in conjunction with the art of medicine will 
we be able to protect our clinical autonomy 
in the future.
Updated growth 
charts now available 
By David Tilstra, MD, 
Medical Director, 
CentraCare Clinic
The Centers for Disease Control and 
Prevention (CDC), with the support of 
the World Health Organization (WHO) and the American
Academy of Pediatrics (AAP) have recommended that
growth charts for infants and children 0-2 years of age 
be updated. The previous growth charts were created by 
the CDC based on a large, but unselected, cross-section 
of American children between the 1970s and 1990s. They
officially should be referred to as a “growth reference.” 
The recommended WHO charts are based on 882 children
who were closely followed to be certain that children 
with chronic illness and/or malnutrition were excluded 
from the data set. The children were breast fed, came 
from a variety of ethnic groups and from a high
socioeconomic status (to eliminate economic concerns
affecting nutrition status). 
The WHO charts are similar, but not exactly the same 
as the CDC charts. The CDC charts tended to inappropriately
identify as many as 7-11 percent of children as underweight,
causing significant parental worry, inappropriate testing and
referrals and unnecessary expense. The WHO charts in a
typical practice will show about three percent of children 
as underweight, as might be expected from using a 
definition of two standard deviations below the mean. 
This should result in many more “true positives,” with
children with real disease conditions being referred for
further evaluation.
There will be some downsides to using the WHO charts
because the charts don’t match the CDC 2-20 year growth
charts so some children will shift height and weight
percentiles when switching to the older age charts. The 
WHO growth charts for older children have not been
endorsed for the United States by the CDC or the AAP. 
The WHO charts can be obtained online at 
www.cdc.gov/growthcharts/who_charts.htm.
A practical tip for hairy lacerations
Lacerations of the scalp or other hairy areas of
the body can be made more challenging by the
fact that hair around a laceration always seems 
to get in the way when you are trying to close
the wound. As an alternative to trimming the hair 
around a laceration on the scalp or on a hairy
leg, try using antibiotic ointment to mat the hair
down and direct it away from the wound.
Another practical ‘Q’ tip
Cotton swabs dipped in water and frozen in
individual plastic bags can provide quick relief
for a burned tongue or lip or a tooth that is
almost out. They also can help stop bleeding 
in the mouth or nose.
My father, the Internist, calls me “The Externist”; a
dermatologist and “photophobe” whose mission is to
prevent and treat skin cancers. He also ribs me about my
children becoming Vitamin D-deficient since they are
covered head-to-toe with hats, rashguards, board shorts, 
and sunscreen when visiting beautiful Green Lake in the
summer. I tell him the American Academy of Dermatology
(AAD) is proud of my efforts to limit ultraviolet exposure
in my family and patients and instead recommend an
adequate amount of Vitamin D be obtained from a healthy
diet and oral supplementation with Vitamin D when needed
(see aad.org for the AAD’s response to how much Vitamin
D is necessary).
Basal cell carcinoma (bcc) and squamous cell carcinoma
(scc) are the most common forms of skin cancer affecting
one in five Americans during their lifetimes. They arise on
sun-exposed areas of the body and may present as non-healing
or easily-bleeding growths. Bcc can present as a pearly pink
telangiectatic papule with or without ulceration and scale,
and scc, as a non-healing hyperkeratotic papule. Superficial
basal cell carcinoma can masquerade as the “eczema” that
doesn’t respond to topical steroids and never goes away.
Dermatologists are trained in cutaneous surgery and
histopathology and evaluate and manage cutaneous
malignancies. When detected early, full lesional biopsy may 
be accomplished with either a punch or full scoop-shave; 
at times an incisional or excisional specimen removal.
Various treatment options in a dermatologist’s
armamentarium include chemotherapeutic topicals such 
as 5-fluorouracil, diclofenac gel, imiquimod cream; also
cryotherapy; eletrodessication and curettage, excision, 
and Mohs micrographically-controlled surgery (MMS).
MMS is a method of removing skin cancers with margin
control while sparing normal tissue. It is used for skin
cancer recurrences (primarily bcc and scc) and for
cutaneous malignancies on areas where tissue-sparing is
required, such as the face, head, neck, hands.
Typically, the patient’s skin cancer is delineated with a
Gentian violet pen. The area is locally anesthetized and the
skin cancer is removed with a scalpel encompassing the
whole tumor (and some, sparingly, 1-2 mm of normal skin).
A drawing (map) is made of the tumor with dye placement
and strategic hatch marks for orientation.
Next, the specimen is processed in our Mohs laboratory; 
it is frozen and cut by a trained histotechnician, such 
that all margins and the deepest margin can
be fully evaluated. Think of the tumor as a
Jell-o mold placed upside down on a plate
that is cut from the plate-side first. The slides
are then stained and microscopic examination by the Mohs
dermatologic surgeon proceeds. The surgeon acts as both
pathologist and dermatologic surgeon in this method. Areas
of tumor involvement are marked on the drawing/map or in
the case of being clear of tumor on all margins, declared
negative for further malignancy. Only areas of tumor
involvement are removed in subsequent stages until 
tumor-free or until Mohs can no longer proceed.
The patient’s resultant defect following tumor removal 
is then repaired. The whole process may take 30 minutes 
to several hours. The recurrence rates after Mohs are as 
low as 1-3 percent. Patients appreciate the convenience 
of having their skin cancer treated and cleared in typically
one visit.
For more about Mohs surgery, visit The American Society
of Mohs Surgery Web site at www.mohssurgery.org 
or to make a referral, please call the CentraCare Clinic
Dermatology Department at (320) 229-4924.
Mohs Micrographically-controlled Surgery for 
Non-Melanomatous Cutaneous Malignancy
By Christina Anderson, MD, Dermatologist, CentraCare Clinic
Determining barriers to patient compliance
By Allen Horn, MD
Poor adherence is a problem we all confront regularly.
When prescribing a long-term medication, such as lisinopril
for hypertension, I initially write the prescription for a 
one-month supply, plus refills, and schedule a follow-up
visit two months later. If at this visit the patient is not doing
as well as expected, I ask the patient to tell me how
she is taking the medication. The answer is usually
“You told me to take one pill a day” or “The bottle
says take one a day.” I then ask how many bottles
she has finished. Too often, the patient admits she
is still on the first bottle. Having confirmed in a
non-threatening manner that the patient is not
taking the prescription as instructed, it is important
to determine what barriers are preventing the
patient from taking her medication as prescribed.
Therefore, without any need for lecturing or scolding, the
patient’s problem with compliance can be discovered and, 
in a subtle way, the patient can be helped to realize that 
the medication can’t be expected to work when it remains 
in the bottle.
Attempts at peering into body cavities without making 
large incisions began in the 1800s with tubes and
magnifying lenses using candlelight. The modern era 
of minimally invasive surgery began in the late 1990s 
with the availability of laparoscopes using attached video
cameras and fiberoptic light sources. The report of 1989
describing removal of the gallbladder through “band-aid”
incisions forever changed the nature of surgery, and led to
attempts to incorporate this technology into other areas.
Very quickly, this instrumentation was introduced into 
chest surgery and had the same revolutionary effect on 
this field as it had on abdominal surgery.
Traditional open chest surgery (thoracotomy) remains
significantly traumatic to the patient and results in prolonged
disability. This is especially concerning for patients with
respiratory compromise. Major chest wall muscles are cut
and the ribs have to be spread apart. But for most of a
century, this was the only approach available for working 
in the chest.
With thoracoscopy, typically three small incisions are 
made and the surgeon works with instruments introduced
between the ribs. The thoracoscope is identical to the
laparoscope. A special bifurcated endotracheal tube is
placed by anesthesia (as is done in 
traditional chest surgery) so the lung 
on the operated side collapses. 
Uses for thoracoscopy include lung biopsy, lung nodule
resection for diagnosis, treatment of pneumothorax,
treatment of empyema and hemothorax, resection or biopsy
of mediastinal masses, and now lung cancer surgery.
A stapling device (the diameter of a finger) is used to
transect lung tissue or major vessels. Using the stapler, 
a generous wedge of lung tissue can be removed for
diagnostic purposes, a lung nodule can be resected, or lung
tissue with blebs causing pneumothorax can be removed.
Other instrumentation allows complete clearing of
empyema loculations, old blood clots from trauma and
removal of any rind which might be trapping the lung. 
In select patients, lobectomy for cancer can be performed.
Like laparoscopy, thoracoscopy has been a welcome
addition to the surgeon’s armamentarium allowing us to
help patients in a minimally invasive, less traumatic way.
For more information or to make a referral, please call
CentraCare Clinic Surgery Department at (320) 252-3342.
Minimally invading the chest: 
Thoracoscopy in modern surgery
By James Jost, MD, General Surgeon, CentraCare Clinic
Introducing our new CentraCare Clinic Specialists
Endocrinology     Health Plaza, (320) 229-5000
Sindhu Devani, MD
Medical degree: Grant Medical School in Bombay, India
Residency: Internal Medicine at Westchester New York Medical College in New Rochelle, NY
Fellowship: Endocrinology and Metabolism at State University of New York in Buffalo
Clinical Interests: All aspects of clinical endocrinology
Partners: Susan Atamian, MD Mark Holm, MD Sarah Swarts, MD
Christopher Balkany, MD Katherine Pillote, MD
Hospital Medicine     St. Cloud Hospital, (320) 250-2678
John Oyakhire, MBBS
Medical School: University of Ibadan College of Medicine in Nigeria
Residency: Internal Medicine at the Medical College of Georgia in Augusta
Partners: Olayiwola Adetunji, MD Khadir Kakal, MD Todd Severnak, DO
Hanadee Alameldin, MBBS Paul Marek, MD Shweta Sharma, MBBS
Christopher Aronson, MD Eric McFarling, MD Mary Joy Sia Su, MD
Sarah Carter, MD Joseph Mercuri, MD Walter Sia Su, MD
Darren Chihos, MD Ravikanth Nathani, MBBS Jeremy Skramsted, MD
Arihant Dalal, MBBS Brian Nelson, MD Peter Waldusky, MD
Sheri Haroldson, MD Holly Peterson, MD Darin Willardsen, MD
Access all CentraCare Clinic physician bios online at www.centracare.com
Affordable Care Act brings Medicare changes
By Paula Lijewski, CPC; Connie Goulet, CPC; Sue Stein, CPC, Compliance Specialists, CentraCare Clinic
As a result of the Affordable Care Act (ACA), Medicare
now allows an annual wellness visit (AWV), including
personal prevention plan services (PPPS). 
Eligibility
AWV: Medicare will pay for an AWV for a beneficiary who
is 12 months past the effective date of his/her first Medicare
Part B coverage period, and who has not received either an
IPPE or an AWV providing PPPS within the past 12 months.
Medicare pays for one first AWV (HCPCS G0438) per 
beneficiary per lifetime. All wellness visits after that must 
be billed as a subsequent AWV (HCPCS G0439). 
IPPE (i.e. Welcome To Medicare): Beneficiaries in their 
first 12 months of Part B coverage will continue to be 
eligible for only the IPPE. Medicare continues to pay for 
only one IPPE per beneficiary per lifetime. 
Deductible and Coinsurance
AWV: As a result of the ACA, the Medicare deductible and 
coinsurance for the AWV (HCPCS G0438 and G0439) are 
waived.
IPPE: As a result of the ACA, the Medicare deductible and
coinsurance (for HCPCS code G0402 only) are waived for
the IPPE provided on or after Jan. 1, 2011.
HCPCS codes used to bill the AWV
For the first AWV provided on or after Jan. 1, 2011, the
health professional shall bill HCPCS G0438 (Annual
wellness visit, including PPPS, first visit). This is a once
per lifetime allowable Medicare benefit.
All subsequent AWVs shall be billed with HCPCS G0439
(Annual Wellness Visit, including PPPS, subsequent
visit). If a beneficiary selects a new health professional to
complete a subsequent AWV, the new health professional
must bill the subsequent AWV with HCPCS G0439.
First AWV services providing PPPS (HCPCS G0438) are a
‘one-time’ Medicare benefit and include the following elements
furnished to an eligible beneficiary by a health professional: 
• Establishment of the individual’s medical/family history; 
• Establishment of a list of current providers and 
suppliers who are regularly involved in providing 
medical care to the individual;
• Measurement of the individual’s height, weight, body 
mass index (or waist circumference, if appropriate), 
blood pressure (BP), and other routine measurements 
as deemed appropriate, based on the individual’s 
medical and family history; 
• Detection of any cognitive impairment the individual 
may have;
• Review of an individual’s risk factors for depression, 
including current or past experiences with depression or 
other mood disorders. This is based on an appropriate 
screening instrument for persons without a current 
diagnosis of depression. The health professional may use 
standardized screening tests designed for this purpose and 
recognized by national professional medical organizations; 
• Review of the individual’s functional ability and level 
of safety, based on direct observation of the individual, 
or the use of appropriate screening questions or a 
screening questionnaire. The health professional may 
use standardized screening tests designed for this 
purpose and recognized by national professional 
medical organizations; 
• Establishment of a written screening schedule for the 
individual, such as a checklist for the next five to 10 years, 
as appropriate, based on recommendations of the 
United States Preventive Services Task Force (USPSTF)
and Advisory Committee of Immunizations Practices 
(ACIP), as well as the individual’s health status, 
screening history and age-appropriate preventive 
services covered by Medicare;
• Establishment of a list of risk factors and conditions of 
which primary, secondary, or tertiary interventions are 
recommended or underway for the individual, including 
any mental health conditions or any such risk factors or 
conditions identified through an IPPE, and a list of 
treatment options and their associated risks and benefits;
• Furnishing of personalized health advice to the 
individual and a referral, as appropriate, to health 
education or preventive counseling services or 
programs aimed at reducing identified risk factors and 
improving self-management or community-based 
lifestyle interventions to reduce health risks and 
promote self-management and wellness, including 
weight loss, physical activity, smoking cessation, 
fall prevention and nutrition; 
• Voluntary advance-care planning upon agreement 
with the individual;
• Any other element(s) determined appropriate by the 
Secretary through the National Coverage Determination
(NCD) process. 
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Subsequent AWV services providing PPPS (HCPCS G0439)
include the following elements furnished to an eligible
beneficiary by a health professional: 
• Update to the individual’s medical/family history; 
• Update of the list of current medical providers and 
suppliers who are regularly involved in providing 
medical care to the individual, as that list was 
developed for the first AWV providing PPPS;
• Measurements of an individual’s weight (or waist 
circumference), BP, and other routine measurements 
as deemed appropriate, based on the individual’s 
medical and family history; 
• Detection of any cognitive impairment the individual 
may have; 
• Update to the individual’s written screening schedule 
developed at the first AWV providing PPPS; 
• Update to the individual’s list of risk factors and 
conditions for which primary, secondary, or tertiary 
interventions are recommended or are underway 
for the individual, as developed at the first AWV 
providing PPPS;
• Furnishing of appropriate personalized health advice 
to the individual and a referral, as appropriate, to 
health education or preventive counseling services 
or programs; 
• Voluntary advance-care planning upon agreement 
with the individual, and; 
• Any other element determined appropriate by the 
Secretary through the NCD process. 
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